HCV-796 and Midazolam Drug Interaction Study in Healthy Subjects

Completed · Phase 1

Conditions studied: Healthy

In brief

To evaluate the potential PK interaction of multiple oral doses of HCV-796 and a single oral dose of midazolam when coadministered to healthy subjects.

Key facts

Study ID

NCT00410254

Run by

Wyeth is now a wholly owned subsidiary of Pfizer

People needed

38

Starts

2007-06-01

Expected to finish

2007-08-01

Last updated by the study team

2007-12-05

Who can join

Age: 18 and older, up to 50. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Healthy as determined by investigator on the basis of medical history, physical examination, clinical laboratory test results, vital signs and 12-lead ECG.

Where it is running

• Study site — Gainesville, Florida, United States
• Study site — Philadelphia, Pennsylvania, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.